Cefdinir Dosing and Treatment Guidelines for Sinus Infection

Introduction to Cefdinir Treatment

The American Academy of Otolaryngology-Head and Neck Surgery recommends cefdinir as a first-line option for adults with mild acute bacterial sinusitis who have not received antibiotics in the previous 4-6 weeks 1, 2
Cefdinir is an appropriate alternative for patients with penicillin allergy, as second- and third-generation cephalosporins have negligible cross-reactivity risk 3

Cefdinir ranks in the 83-88% predicted clinical efficacy tier, slightly below respiratory fluoroquinolones (90-92%) but comparable to high-dose amoxicillin and other advanced cephalosporins 1, 2

If no improvement occurs after 72 hours, switch to alternative therapy or re-evaluate the diagnosis 1, 2
Consider switching to high-dose amoxicillin-clavulanate (4 g/250 mg per day) or a respiratory fluoroquinolone (levofloxacin, moxifloxacin) 1, 2, 4

Do not use cefdinir for patients with moderate-to-severe disease or recent antibiotic exposure—these patients require more aggressive initial therapy 1, 2
Avoid using first-generation cephalosporins (cephalexin, cefadroxil) or cefaclor for sinusitis, as they have inadequate coverage against H. influenzae and high rates of adverse reactions 3
Complete the full 10-day course even if symptoms improve earlier to prevent relapse and resistance development 4
Reassess at 72 hours if no improvement to avoid delayed treatment of resistant organisms 1, 2, 4